Ultragenyx Pharmaceutical shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Ultragenyx Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Ultragenyx Pharmaceutical held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ultragenyx Pharmaceutical by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $7.4M | 155k | 47.82 |
| 2023-09-30 | $14M | 391k | 35.65 |
| 2023-06-30 | $25M | 537k | 46.13 |
| 2023-03-31 | $18M | 445k | 40.10 |
| 2022-12-31 | $52M | 1.1M | 46.33 |
| 2022-06-30 | $51M | 860k | 59.66 |
| 2022-03-31 | $56M | 767k | 72.62 |
| 2021-12-31 | $61M | 726k | 84.09 |
| 2021-09-30 | $46M | 506k | 90.19 |
| 2021-03-31 | $97M | 849k | 113.86 |
| 2020-12-31 | $133M | 964k | 138.43 |
| 2020-09-30 | $36M | 438k | 82.19 |
| 2020-06-30 | $40M | 506k | 78.22 |
| 2019-12-31 | $24M | 557k | 42.71 |
| 2019-09-30 | $17M | 396k | 42.78 |
| 2019-06-30 | $26M | 404k | 63.50 |
| 2019-03-31 | $34M | 495k | 69.36 |
| 2018-12-31 | $13M | 301k | 43.48 |
| 2018-09-30 | $23M | 304k | 76.34 |
| 2018-06-30 | $19M | 243k | 76.87 |
| 2018-03-31 | $27M | 528k | 50.99 |
| 2017-12-31 | $25M | 537k | 46.38 |
| 2017-09-30 | $39M | 738k | 53.26 |
| 2017-06-30 | $37M | 590k | 62.11 |
| 2017-03-31 | $28M | 417k | 67.78 |
| 2016-12-31 | $28M | 403k | 70.31 |
| 2016-09-30 | $48M | 677k | 70.94 |
| 2016-06-30 | $32M | 656k | 48.91 |
| 2016-03-31 | $35M | 560k | 63.31 |
| 2015-12-31 | $52M | 466k | 112.18 |
| 2015-09-30 | $76M | 793k | 96.31 |
| 2015-06-30 | $26M | 255k | 102.33 |
| 2015-03-31 | $16M | 252k | 62.07 |
| 2014-12-31 | $13M | 291k | 43.88 |
| 2014-03-31 | $6.1M | 125k | 48.89 |